(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 06, 2026 (GLOBE NEWSWIRE) -- "Interventional Cardiology Devices Market Size, Share & Trends Analysis Report by Product, Procedures, End Use, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering. The global interventional cardiology devices market was valued at an estimated USD 11.3 billion in 2025 and is projected to reach USD 19.8 billion by 2033. The market is expected to expand at a compound annual growth rate of 7.3% from 2026 to 2033, supported by the rising prevalence of cardiovascular disease and growing demand for minimally invasive cardiac procedures.
Key interventional cardiology devices market growth factors include increasing rates of obesity, hypertension and diabetes, alongside aging populations, sedentary lifestyles and unhealthy diets. These risk factors are contributing to a sustained increase in coronary artery disease, acute myocardial infarction and chronic total occlusion cases, strengthening demand for advanced diagnostic and therapeutic devices across hospitals, cath labs and specialized cardiac facilities.
The scale of cardiovascular disease remains a major public health concern. In October 2024, the CDC reported that cardiovascular disease caused 919,032 deaths in the U.S. during 2023. Coronary heart disease accounted for 371,506 deaths. Approximately 1 in 6 cardiovascular disease deaths occurred among adults younger than 65. The U.S. also recorded an estimated 805,000 heart attacks, including approximately 605,000 first-time events.
Market Segmentation
The report provides global, regional and country-level revenue forecasts and evaluates key market trends across product, procedure, end-use and geographic segments from 2021 to 2033.
Product Outlook
Coronary stents, including Drug-Eluting Stents (DES), Bare Metal Stents (BMS) and Bioresorbable Scaffolds (BRS) PTCA balloon catheters, including normal, specialty and Drug-Coated products Intravascular imaging catheters and pressure guidewires Accessory devices, including PTCA guidewires, PTCA guiding catheters and introducer sheaths
Innovation across coronary stents, balloon catheter technologies, intravascular imaging systems and pressure guidewires is expected to influence purchasing decisions and clinical adoption. Product development focused on procedural accuracy, safety and improved patient outcomes will remain central to competition in the interventional cardiology devices industry.
Procedure Outlook
Coronary Artery Disease (CAD) Acute Myocardial Infarction (AMI) Chronic Total Occlusion (CTO)
End-use Outlook
Hospitals Cath labs Ambulatory Surgical Centers (ASCs) Specialty cardiac centers
Hospitals and cath labs represent important care settings for interventional cardiology procedures, while Ambulatory Surgical Centers (ASCs) and specialty cardiac centers offer additional market opportunities as healthcare systems expand access to efficient, procedure-focused treatment environments.
Regional Outlook
North America: U.S., Canada and Mexico Europe: UK, Germany, France, Italy, Spain, Denmark, Sweden and Norway Asia Pacific: Japan, China, India, Australia, South Korea and Thailand Latin America: Brazil and Argentina Middle East & Africa: South Africa, Saudi Arabia, UAE and Kuwait
The geographic analysis enables companies to assess regional demand, compare market conditions and identify expansion opportunities. It also examines country-level trends that may affect device adoption, healthcare investment and competitive positioning.
Strategic Value of the Report
Detailed market intelligence to support informed business decisions Revenue estimates and forecasts across major products, procedures, end-use settings and regions Analysis of market growth opportunities, industry trends and demand drivers Competitive landscape and market share insights Strategic recommendations designed to identify potential revenue streams Coverage of product innovation and emerging commercial opportunities
The report equips medical device manufacturers, healthcare providers, investors and other stakeholders with actionable insights into the global interventional cardiology devices market. Its assessment of market dynamics, segmentation, competition and innovation can support product planning, geographic expansion, investment evaluation and long-term growth strategies through 2033.
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment